Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
15 cents/share income Mar qrtr 2013
bought 1 million gold at 25.50/oz or 40k shares at .44 or 17,600/25.5=690 oz(before costs)
Market Cap + Debt = 102 million/resource base 4 million oz= 25.50/oz + 1000 recovery cost.
Good way to buy Gold in ground.
Company blows out stock 807 million shares for 2.5 million in convertable notes or .003/ share.
So your now down 40k with 5 k per cent downside. Give us a break.
Time to buy with PBKEF at 10.2 x 1.1 = 11.22 value
PBEGF 11.85 -11.22 = .63/ share
Time to buy. 11.30x1.1=12.43.
12.60-12.43=.17/sh
Nice volume spike first 90 minutes. Should go higher with follow through.
HUSA uses gold in drilling mud?
Dollars spent 9 mths 2012 - $24,030,938/36916/.375= $1785/ft
Holes drilled:
Zorro Gris 1 Well 11898'
Cachirre 1 Well 9486'
Tamandua 1 Well 15562
Total 36916'
What is wrong with this picture?
1546 Bbl/day X $50k/ flowing baffle X .375 = Current Market Cap 29 million.
6000 Bbl/day = current price X 4
In addition the CPO 4 tract could easily contain 100 million barrels of reserves at $10/ barrel equals 1 Billion X .375 = 375 million / 67.3 million shares (fully diluted). = $ 5.57/ share.
42 cents cash/share
37.7 million shares June 30, 2012 + 14.8 million shares for 10 million cash = 26 million- 4million (Husa share of Zorro Gris well) = 22 million/ 52.5 million shares = 41.9 cents/ share.
20 day moving average is 1.08. Base forming here 1.08-1.12. Has to digest news rally from 2 days ago and news of new stock issuance from yesterday. Down with overall market. Time to reload.
As Andrew Prince owns 26.4% of common shares and he also owns 76% of preferred shares he is foreclosed from converting his preferred by stipulations that disallow him to own over 5% of the common shares after conversion. Same for Alex Kreger who owns 7% of preferred shares.
With $3 million net income projected for next 12 months the expected EPS per share based on 4.91 million shares of common is 61 cents per share. Assuming a PE of 5 this would make a share price north of $3. Someone is definitely buying up float on this; every time someone drops bid it is bought and ask is changed to .24. 1.6 million float could be bought for $384,000. at .24.
uhh, 128,000,000 shares minus 35,000,000 by insider equals 93,000,000 float. The daily volume seems high at 71,000,000.
Since Alex Kreger and Andrew Prince each currently own over 5% of common they are unable to convert preferred. The only ones that can convert and bring their total shares to 5% are:
Robert Adler 54,000
David Barger 184,000
Others 992,000
___________
Total 1,230,000
Existing 3,688,497
___________
Total 4,918,497 max available
equity 3,552,713/4,918,467= 72cents per share
Since Alex Kreger and Andrew Prince each currently own over 5% of common they are unable to convert preferred. The only ones that can convert and bring their total shares to 5% are:
Robert Adler 54,000
David Barger 184,000
Others 992,000
___________
Total 1,230,000
Existing 3,688,497
___________
Total 4,918,497 max available
equity 3,552,713/4,918,467= 72cents per share
Insiders could be anticipated higher EPS in 2nd quarter. Big acquisition with deferred debt payments
would boost revenue and EPS. Low liquidity would push this much higher in the event of positive numbers or news of same.
As far as financials: no phone , no pool, no pets. GWBU ran to 600 million market cap before crashing. With 500 million shares out this should be good to at least 50 million.
Support on 15 min bar chart .96-1.00. Need volume to get this moving. Can't believe this hasn't attracted more attention. New more effective treatment against cancer and people are actually buying crap like GWBU and ignoring this. Treatment against prostate cancer 98-100% effective.
Isoray with exclusive patents for Cesium 131 is more powerful and effective than conventional brachytherapy. 7000 successful prostate treatments so far. FDA approval for cancer treatment on all body sites.
Preferred shares outstanding Dec 2011 3 million
Common shares outstanding Dec 2011 33.2 million
Total 35.2 million
1 for 2 split Mar 12, 2012 17.6 million shares
Enterprise Value 81.6 m cash equiv - 6 m debt and 27 m market cap = 48.6 m/17.6 m
Value of shares in event of liquidation $2.70 + 1.53 = $4.23
2 for 1 reverse split mar 12, stock was at 1.47. 2x1.47=2.94 16.6million outstanding shares. 30 million revenue thru June 11, 2011. $7.57 book value and 4.27 cash per share. Insiders own most of stock. Potential for $3 if volume follows thru tomorrow.
202 million boe proven and probably figuring 6% recovery. 5.3 billion/202 million = $24 boe. Now figure 24% recovery valuation drops to $6 boe.
Co issued 750 million in junk bonds to buy back conv debt and operate.
210 million market cap for company with no Vit k in vitamen. Wow!
Pennant Breakout 2.64-2.65 on 30 min bar charts
Andy Prince gain on purchase of preferred in event of liquidation:
Shares Purchased 4,497,962
Outstanding Preferred 11,764,055
% Owned 38%
Equity 3,921,713
% .38
1,490,250
Cost 314,857
Potential Gain 1,175,393
Preferred has liquidation preference of $4,750,000
Preferred Shares before recent purchases: 6,462,378
Preferred recently purchased : 5,283,655
Total 11,746,053
X conversion rate 1.55 18,206,382
Common Shares 2,865,079
Total Dilution 21,071,461
Book Value on diluted basis $3,921,713/ 21,071,461=19 cents/ share
Net Income past 9 months to Sept 30 - 2,397,835
Impairment Charge +2,558,180
Difference 160,345
Net income on diluted basis .008
The 10K references 6.4 million shares convertable into 10 million shares. Hope they converted 5.3 million for the long haul.
Shares out 2.8 million to 8.1 million
Cash up 480k to 850k
Book Value $1.24 to 48 cents
Liked this better before dilution.
So bond holders convert 646 million debentures into 64 million shares. Outstanding shares go from 187 million to 251 million. The debentures are off the finanacial statement and market cap plus debt stays the same; approx. 5.5 Billion. The stock currently yields 10% and forecasts production at 49,000 BOEPD. Compare this to Marathon with current production of 40,000 BOEPD and a market cap and debt of 33.5 Billion and you can see what a sleeper this is. The biggest problem is the lack of liquidity and being a subsidary of Petrobank. Also being on the pink sheets doesn't help.
June 8 2011 Market Cap = $1.55x 16.7 million shares = $25.8 million.
Nov 9 2011 Market Cap = $.70 x 75.6 million shares = $ 52.9 million.
Reduction in debt $33 million / 75.6 million shares = $.43 per share
Adjusted market cap = .70 - .43 = .27 x 75.6 million = $20.42 million
Price needed to equal June 9, 2011 price: $25.8 + 33 = $58.8 / 75.6 = $ .77
Return to profitability and stronger balance sheet would skew this upward.
My Bad, 30 million proved reserves.
MHR Has 426 million barrels of oil of proven reserves or $610 million value at 20 dollars per barrel, and potential value of 426 million barrels or 8.4 billion dollars.
WLSV sold OPTI and FL to UREM for 68% of shares; then forks over shares for payment of debt (Brenen's 100K?).
WLSV sold company to Janel. Janel sues and pays shares to individual officers of WLVS.
Value of WLSV 50-100K as shell or .007.
Credo Petroleum reports 1-3% working interest in Enerplus Ethan Hall with initial production of 3,732 BOEPD.
Bought 5k at bid. Like to keep this turd up. Own 1/3 Float.
Likes:
1. Sould hit $1 if financials hold.
2. Weekly stochastics bottoming.
3. Laden with cash (45 million)
4. Good operating margins(15%)
5. Undervalued (50 million book value)
6 .Diversified out of US dollar.
7. 22 million gain on sale of Pharmacy
8. Good increases in volume on daily and weekly charts.
9. Lower volume on down days.
10. Potential new distrbution arm (HBHLZY)
11. Weekly charts bouncing along bottom.
12. Previously a 6 dollar stock with same number of shares.
13.Hosting 5th annual BioPharma conference Mar 19, 2012
Don,t like:
1. Series of appointments and resignations of CFO and CEOs.
2. Pharmacy distaste for public company; what? so they don't have to tell the truth?
3. Build up of account receivables to 31 million on Sept 30, 2009. 30% of sales.
4. Missing and lying about April 15 due date for 10k.
5. Resignation Davis Accounting Group.
6. Illiquidity and large bid/ask spread.
7. Unaudited financial statements for 2008, 2009, Sept 30 2010.
8. Waiting for bomb to drop from new accountants.
Do like:
Everything else.